Comparison of clinical efficacy between decitabine combined with half the amount of CAG regimen with CAG regimen alone in patients with inermediate to high-risk myelodysplastic syndrome
BIO Web Conf., 8 (2017) 01024
DOI: https://doi.org/10.1051/bioconf/20170801024